摘要
简要介绍了用于治疗心脑血管病的几种溶血栓药物 ,对 1～ 3代溶栓药的结构和特点进行了比较。并就第三代溶栓药的代表———瑞替普酶的国内外研究开发。
Some thrombolytic d rugs in treating cerebro-cardiovascular diseases were briefly reported. The cha racteristics of structure and effect of the third-generation thromblytics were compared with those of the first-and second-generation drugs. The status of th e development and application of Reteplase,which is a representive of the third -generation thromblytics and is possible to be industrialized recently in China ,was especially introduced.
出处
《药学进展》
CAS
2004年第2期72-75,共4页
Progress in Pharmaceutical Sciences
